Picture of Longeveron logo

LGVN — Longeveron News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Brief: Longeveron Reports Q4 Revenue Of $200,000

March 11 (Reuters) - Longeveron Inc  LGVN.O :
    * Q4 LOSS PER SHARE $0.20
    * Q4 REVENUE $200,000
    * JAPANESE PHASE 2 AGING FRAILTY TRIAL EXPECTED TO INITIATE IN FIRST HALF OF
2022
    * BELIEVE THAT EXISTING CASH AND SHORT-TERM INVESTMENTS WILL BE SUFFICIENT
TO
COVER EXPENSES AND CAPITAL REQUIREMENTS INTO 2024
    * CASH AND SHORT-TERM INVESTMENTS WAS $35.0 MILLION COMPARED TO $0.8 MILLION
AS OF
DECEMBER 31, 2021 AND 2020, RESPECTIVELY

Source text for Eikon:  ID:nGNX6N9sy0 
Further company coverage:  LGVN.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Longeveron

See all news